中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共39条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-kappa B-HIF-2 alpha-SerpinB3 Pathway 期刊论文
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 卷号: 2022
作者:  Li, Jun-Fei;  Zheng, Xiao-Rong;  Zhang, Hong-Yan;  Shen, Chang-Ming;  Shen, Guo-xin;  Jiang, Jian-Wei
收藏  |  浏览/下载：45/0  |  提交时间：2022/12/23
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study 期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:  Wang, Wenxian;  Lin, Gen;  Guan, Yelan;  Zhang, Yuxin;  Xu, Chunwei;  Wang, Qian;  Wang, Dong;  Jiang, Zhansheng;  Cai, Jing;  Lou, Guangyuan;  Song, Zhengbo;  Zhang, Yongchang
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
Thymic carcinoma  Immunotherapy  PD-1  Efficacy  Immune-related adverse events  
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文
CANCERS, 2022, 卷号: 14
作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui;  Zhu, Liang;  Sheng, Jiamin;  Zhou, Zichao;  Fan, Yun
收藏  |  浏览/下载：40/0  |  提交时间：2022/12/22
liver metastasis  non-small cell lung cancer  PD-L1  PD-1  PD-L1 inhibitor  CD8+T cell  
Gene expression profile of human colorectal cancer identified NKTR as a biomarker for liver metastasis 期刊论文
AGING-US, 2022, 卷号: 14
作者:  Bai, Rui;  Shi, Zhong;  Li, Dan;  Zhou, Donger;  Ge, Wei-Ting;  Zheng, Shu
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23
colorectal cancer  liver metastasis  NKTR  proliferation  migration and invasion  
Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11
作者:  Zhang, Yanqiang;  Xu, Xiaoqing;  Hu, Can;  Du, Yian;  Ding, Guangyu;  Chen, Jiahui;  Zhu, Xiu;  Xu, Zhiyuan;  Wei, Qing
收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23
Gastric cancer  HER2-positive  conversion therapy  
CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Yuan, Li;  Xu, Jingli;  Shi, Yunfu;  Jin, Zhiyuan;  Bao, Zhehan;  Yu, Pengcheng;  Wang, Yi;  Xia, Yuhang;  Qin, Jiangjiang;  Zhang, Bo;  Yao, Qinghua
收藏  |  浏览/下载：28/0  |  提交时间：2022/12/23
gastric cancer  cd3d  tumor infiltrating lymphocytes (TILs)  prognosis  PD-L1  
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Lin, Yuxin;  Zhu, Wei;  Wu, Bingchen;  Lan, Huiyin
收藏  |  浏览/下载：46/0  |  提交时间：2022/05/16
Sarcoid-like reaction  immune checkpoint inhibitor  Toripalimab  PD-1  case report  
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming;  Wang, Xiao-Jia;  Shao, Xi-Ying
收藏  |  浏览/下载：41/0  |  提交时间：2021/11/01
Advanced breast cancer (ABC)  aromatase inhibitors (AIs)  everolimus (EVE)  fulvestrant (FUL)  retrospective study  
MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway 期刊论文
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021
作者:  Qi, Yajun;  Fang, Qilu;  Li, Qinglin;  Ding, Haiying;  Shu, Qi;  Hu, Yan;  Xin, Wenxiu;  Fang, Luo
收藏  |  浏览/下载：76/0  |  提交时间：2021/09/06
Hepatocellular carcinoma (HCC)  myeloid differentiation protein 2 (MD2)  epidermal growth factor receptor (EGFR)  migration  invasion  
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens 期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021
作者:  Cao, Fei;  Zheng, Jiaping;  Luo, Jun;  Zhang, Zhewei;  Shao, Guoliang
收藏  |  浏览/下载：59/0  |  提交时间：2021/08/30
Regorafenib plus DEB-TACE  CRLM  Treatment response  Prognosis  Adverse events